Synthesis and In Vitro Screening of Novel Heterocyclic β-d-Gluco- and β-d-Galactoconjugates as Butyrylcholinesterase Inhibitors

Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry
Krešimir BaumannSrđanka Tomić

Abstract

The development of selective butyrylcholinesterase (BChE) inhibitors may improve the treatment of Alzheimer's disease by increasing lower synaptic levels of the neurotransmitter acetylcholine, which is hydrolysed by acetylcholinesterase, as well as by overexpressed BChE. An increase in the synaptic levels of acetylcholine leads to normal cholinergic neurotransmission and improved cognitive functions. A series of 14 novel heterocyclic β-d-gluco- and β-d-galactoconjugates were designed and screened for inhibitory activity against BChE. In the kinetic studies, 4 out of 14 compounds showed an inhibitory effect towards BChE, with benzimidazolium and 1-benzylbenzimidazolium substituted β-d-gluco- and β-d-galacto-derivatives in a 10-50 micromolar range. The analysis performed by molecular modelling indicated key residues of the BChE active site, which contributed to a higher affinity toward the selected compounds. Sugar moiety in the inhibitor should enable better blood-brain barrier permeability, and thus increase bioavailability in the central nervous system of these compounds.

References

Oct 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·M HarelJ L Sussman
Jan 1, 1995·Alzheimer Disease and Associated Disorders·C Geula, M M Mesulam
Dec 24, 1997·Annals of Neurology·A L GuillozetM M Mesulam
Nov 9, 2002·Carbohydrate Research·Hong-Min LiuConghai Huang
Jan 18, 2003·Analytical Biochemistry·Peter EyerElsa Reiner
Jun 10, 2003·Alzheimer Disease and Associated Disorders·Sultan DarveshEarl Martin
Jul 1, 1961·Biochemical Pharmacology·G L ELLMANR M FEATHER-STONE
Oct 23, 2004·The Journal of Organic Chemistry·Balaram MukhopadhyayRobert A Field
Feb 21, 2006·NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics·Hassan Pajouhesh, George R Lenz
Sep 5, 2007·Acta Crystallographica. Section F, Structural Biology and Crystallization Communications·Michelle N NgamelueOluwatoyin A Asojo
Nov 30, 2007·Clinical Interventions in Aging·Maria Luisa OnorEugenio Aguglia
Sep 1, 2009·Current Alzheimer Research·Barbara BorroniAlessandro Padovani
Nov 3, 2009·European Journal of Medicinal Chemistry·Maja KatalinićZrinka Kovarik
Mar 17, 2010·Chemico-biological Interactions·Gregory E GarciaVenee I Morthole
Oct 12, 2013·Folia Neuropathologica·R A Armstrong
Sep 17, 2014·Journal of Neurology, Neurosurgery, and Psychiatry·Gennaro PaganoMichele Tagliati
May 31, 2016·Chemico-biological Interactions·Nikola MarakovićGoran Šinko
Sep 23, 2016·Toxicology and Applied Pharmacology·Maja KatalinićZrinka Kovarik
Oct 25, 2016·Toxicology Letters·Valentina BušićDajana Gašo-Sokač
Oct 11, 2017·ACS Chemical Neuroscience·Amit Kumar, Taher Darreh-Shori
Dec 1, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Terrone L RosenberryFlorian Nachon
Aug 17, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Weiam HusseinZafer Asım Kaplancıklı
Feb 23, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Ivica BlaževićIvana Generalić Mekinić
Mar 10, 2019·European Journal of Medicinal Chemistry·Katarina ChalupovaKamil Kuca
Mar 14, 2019·Chemical Communications : Chem Comm·AnŽe MedenUroš Grošelj
Apr 20, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Eva RamosJosé Marco-Contelles

❮ Previous
Next ❯

Methods Mentioned

BETA
acetylation
glycosylation
infrared spectroscopy
column chromatography

Software Mentioned

GraphPad Prism6
CDOCKER

Related Concepts

Related Feeds

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Basal Forebrain- Circuits

Basal forebrain is a region in the brain important for production of acetylcholine and is the major cholinergic output of the CNS. Discover the latest research on circuits in the basal forebrain here.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.